End Stage Renal Disease clinical trials at UC Irvine
3 in progress, 0 open to eligible people
Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis
Sorry, in progress, not accepting new patients
The main purpose of this study is to compare the Human Acellular Vessel (HAV) with ePTFE grafts when used for hemodialysis access.
Irvine, California and other locations
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis
Sorry, in progress, not accepting new patients
The main purpose of this study is to compare the Human Acellular Vessel (HAV) with arteriovenous fistula (AVF) when used for hemodialysis access
Irvine, California and other locations
Incremental Hemodialysis: The TwoPlus Trial
Sorry, not yet accepting patients
This study is to prospectively compare clinical effectiveness between clinically- matched incremental hemodialysis and conventional hemodialysis in patients with incident kidney dysfunction requiring dialysis and residual kidney function.
Irvine, California and other locations
Our lead scientists for End Stage Renal Disease research studies include Connie Rhee, MD.
Last updated: